Figure 2.
Dose-response curve of cell inhibition of ixabepilone on the human LAR-type TNBC cell line MDA-MB-453. IC10 of ixabepilone was 9.94E-011 mol/l LAR, luminal androgen receptor; TNBC, triple-negative breast cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.